Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

Abstract In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had be...

Full description

Bibliographic Details
Main Authors: Christopher J. Rogers, Robert J. Harman, Bruce A. Bunnell, Martin A. Schreiber, Charlie Xiang, Fu-Sheng Wang, Antonio F. Santidrian, Boris R. Minev
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Translational Medicine
Subjects:
COVID-19
SARS-CoV-2
ARDS
Pneumonia
Mesenchymal stem cells
Online Access:http://link.springer.com/article/10.1186/s12967-020-02380-2

Internet

http://link.springer.com/article/10.1186/s12967-020-02380-2

Similar Items